Article
Role of hypoxia-inducible factor-1α as a cancer therapy target
1 Dec 2006
Abstract excerpt
Hypoxia occurs in solid tumours due to a mismatch between tumour growth and angiogenesis. Hypoxia in solid tumours is associated with an aggressive phenotype and resistance to radiation therapy and chemotherapy leading to poor patient prognosis. Hypoxia-inducible factor-1 (HIF-1) is a transcription factor, which is activated in response to intratumoural hypoxia and as a result of genetic alterations that activate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
